Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 88

1.

The vaccine renaissance.

Petrovsky N.

Hum Vaccin. 2011 Feb;7(2):149-52. Epub 2011 Feb 1. No abstract available.

2.

TLR4 agonists as vaccine adjuvants: a chemist's perspective.

Johnson DA.

Expert Rev Vaccines. 2013 Jul;12(7):711-3. doi: 10.1586/14760584.2013.811189. No abstract available.

PMID:
23885814
3.

Soluble multi-trimeric TNF superfamily ligand adjuvants enhance immune responses to a HIV-1 Gag DNA vaccine.

Kanagavelu SK, Snarsky V, Termini JM, Gupta S, Barzee S, Wright JA, Khan WN, Kornbluth RS, Stone GW.

Vaccine. 2012 Jan 17;30(4):691-702. doi: 10.1016/j.vaccine.2011.11.088. Epub 2011 Dec 4.

4.

Novel vaccine delivery systems: solutions to HIV vaccine dilemmas?

Sutter G, Haas J.

AIDS. 2001;15 Suppl 5:S139-45. Review. No abstract available.

PMID:
11816162
5.

Novel adjuvants and delivery systems for HIV vaccines.

O'Hagan DT, Lavelle E.

AIDS. 2002;16 Suppl 4:S115-24. Review. No abstract available.

PMID:
12699008
6.

A novel adjuvant Ling Zhi-8 for cancer DNA vaccines.

Chu CL, Chen DzC, Lin CC.

Hum Vaccin. 2011 Nov;7(11):1161-4. doi: 10.4161/hv.7.11.17753. Epub 2011 Nov 1.

PMID:
22048115
7.

Different domains of glycoprotein 96 influence HPV16 E7 DNA vaccine potency via electroporation mediated delivery in tumor mice model.

Daemi A, Bolhassani A, Rafati S, Zahedifard F, Hosseinzadeh S, Doustdari F.

Immunol Lett. 2012 Dec 17;148(2):117-25. doi: 10.1016/j.imlet.2012.10.003. Epub 2012 Oct 17.

PMID:
23085605
8.

Enhancement of HIV-1 DNA vaccine immunogenicity by BCG-PSN, a novel adjuvant.

Sun J, Hou J, Li D, Liu Y, Hu N, Hao Y, Fu J, Hu Y, Shao Y.

Vaccine. 2013 Jan 7;31(3):472-9. doi: 10.1016/j.vaccine.2012.11.024. Epub 2012 Nov 19.

PMID:
23174201
9.

The search for a potent DNA vaccine against AIDS: the enhancement of immunogenicity by chemical and genetic adjuvants.

Sasaki S, Tsuji T, Asakura Y, Fukushima J, Okuda K.

Anticancer Res. 1998 Sep-Oct;18(5D):3907-15. Review.

PMID:
9854503
10.

DNA vaccine molecular adjuvants SP-D-BAFF and SP-D-APRIL enhance anti-gp120 immune response and increase HIV-1 neutralizing antibody titers.

Gupta S, Clark ES, Termini JM, Boucher J, Kanagavelu S, LeBranche CC, Abraham S, Montefiori DC, Khan WN, Stone GW.

J Virol. 2015 Apr;89(8):4158-69. doi: 10.1128/JVI.02904-14. Epub 2015 Jan 28.

11.

Electroporation as a "prime/boost" strategy for naked DNA vaccination against a tumor antigen.

Buchan S, Grønevik E, Mathiesen I, King CA, Stevenson FK, Rice J.

J Immunol. 2005 May 15;174(10):6292-8.

12.

DNA vaccines for cancer too.

Yu M, Finn OJ.

Cancer Immunol Immunother. 2006 Feb;55(2):119-30. Epub 2005 Jul 20. Review. No abstract available.

PMID:
16032397
13.

GeoVax expands its HIV/AIDS vaccine program.

Riedmann EM.

Hum Vaccin. 2011 Jun;7(6):596. doi: 10.4161/hv.7.6.16769. No abstract available.

PMID:
21955676
14.
15.

Cancer vaccines: an update.

Hipp JD, Hipp JA, Lyday BW, Minev BR.

In Vivo. 2000 Sep-Oct;14(5):571-85. Review.

PMID:
11125541
16.

The potential of topical DNA vaccines adjuvanted by cytokines.

Lisziewicz J, Calarota SA, Lori F.

Expert Opin Biol Ther. 2007 Oct;7(10):1563-74. Review.

PMID:
17916048
17.

Engineering of DNA vaccines using molecular adjuvant plasmids.

Sin JI, Kim J, Chattergoon M, Ayyavoo V, McCallus D, Ugen KE, Boyer JD, Weiner DB.

Dev Biol (Basel). 2000;104:187-98. Review.

PMID:
11713819
18.

Enhancement of HIV DNA vaccine immunogenicity by the NKT cell ligand, alpha-galactosylceramide.

Huang Y, Chen A, Li X, Chen Z, Zhang W, Song Y, Gurner D, Gardiner D, Basu S, Ho DD, Tsuji M.

Vaccine. 2008 Mar 28;26(15):1807-16. doi: 10.1016/j.vaccine.2008.02.002. Epub 2008 Feb 20.

PMID:
18329757
19.

DNA vaccine with α-galactosylceramide at prime phase enhances anti-tumor immunity after boosting with antigen-expressing dendritic cells.

Kim D, Hung CF, Wu TC, Park YM.

Vaccine. 2010 Oct 21;28(45):7297-305. doi: 10.1016/j.vaccine.2010.08.079. Epub 2010 Sep 17.

20.

Cancer vaccines: between the idea and the reality.

Finn OJ.

Nat Rev Immunol. 2003 Aug;3(8):630-41. Review.

PMID:
12974478

Supplemental Content

Support Center